Good rate of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease after three months of treatment: An open-label study

by Luis Felipe José Ravic de Miranda, Marilourdes do Amaral Barbosa, Patrícia Regina Henrique Peles, Patrícia Hilar Pôças, Pedro Augusto Lopes Tito, Rafael de Oliveira Matoso, Thiago Oliveira Lemos de Lima, Edgar Nunes de Moraes, Paulo Caramelli